New Key Statistics Module, Z-Score and F-Score
OTCPK:TKPHF Key Ratios
Market Cap $ M | 44,766.76 |
Enterprise Value $ M | 71,989.43 |
P/E(ttm) | 23.21 |
PE Ratio without NRI | 23.21 |
Forward PE Ratio | 56.97 |
Price/Book | 0.98 |
Price/Sales | 1.43 |
Price/Free Cash Flow | 14.59 |
Price/Owner Earnings | 14.10 |
Payout Ratio % | 1.07 |
Revenue (TTM) $ M | 30,610.00 |
EPS (TTM) $ | 1.23 |
Beneish M-Score | -2.74 |
10-y EBITDA Growth Rate % | 7.40 |
5-y EBITDA Growth Rate % | 8.60 |
y-y EBITDA Growth Rate % | 7.40 |
EV-to-EBIT | 25.96 |
EV-to-EBITDA | 8.63 |
PEG | 2.70 |
Shares Outstanding M | 1,585.18 |
Net Margin (%) | 6.38 |
Operating Margin % | 10.46 |
Pre-tax Margin (%) | 5.93 |
Quick Ratio | 0.77 |
Current Ratio | 1.28 |
ROA % (ttm) | 1.93 |
ROE % (ttm) | 4.05 |
ROIC % (ttm) | 3.64 |
Dividend Yield % | 4.45 |
Altman Z-Score | 1.13 |
TKPHF Number of Guru Trades
TKPHF Volume of Guru Trades
Gurus Latest Trades with OTCPK:TKPHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:TKPHF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Takeda Pharmaceutical Co Ltd Insider Transactions
No Available Data
News about OTCPK:TKPHF
Total 0- 1